Skip to main content
    H

    HealthEquity Inc (HQY)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $101.84
    -2.74 (-2.62%)

    Market Cap: $8.56B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    HealthEquity Inc (HQY) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    HealthEquity (HQY) has a market cap of $8.56B and an enterprise value of $9.26B. Its trailing P/E of 25.0x is below its 10-year median of 40.5x. Its share count is down 3.67% from a year earlier.

    Total Valuation

    Enterprise value is 8.24% above the market cap, as debt exceeds cash.

    Market Cap$8.56B
    Enterprise Value$9.26B
    Latest price (Nov 17, 2026)$101.84

    Key Dates

    The next earnings report is set for Dec 1, 2026, after the close.

    Next Earnings DateDec 1, 2026, after the close
    Last Earnings DateAug 27, 2026
    Fiscal Year EndJanuary

    Share Statistics

    The share count fell 1.23% in the quarter ended Jul 31, 2026 and shrank 2.18% a year over 2 years.

    Shares Outstanding83.37M
    Shares Change (YoY)-3.67%
    Shares Change (QoQ)-1.23%
    Share Count Growth (2Y CAGR)-2.18%

    Valuation Ratios

    Sales and book value multiples are 6.2x and 4.3x. Its year-end P/E ranged from 24.4x to 81.0x from 2016 to 2025.

    P/E Ratio25.0x
    Forward P/E21.3x
    P/S Ratio6.2x
    Forward P/S6.0x
    P/B Ratio4.3x
    P/FCF Ratio19.4x
    P/OCF Ratio17.5x
    PEG Ratio1.7

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 17.7x EBITDA and 21.0x free cash flow.

    EV / Earnings39.2x
    EV / Sales6.8x
    EV / EBITDA17.7x
    EV / EBIT25.6x
    EV / FCF21.0x

    Price Statistics

    The stock is up 0.07% over 52 weeks and trades 5.62% above its 50-day average.

    Beta (1Y)0.45
    52-Week Change+0.07%
    1-Month Change+9.42%
    3-Month Change-2.03%
    6-Month Change+20.31%
    5-Year Change+54.84%
    10-Year Change+208.37%
    Total Return (1Y)+0.07%
    Total Return (3Y CAGR)+14.80%
    Total Return (5Y CAGR)+10.13%
    Return vs SPY (1Y)-12.44%
    Max Drawdown (1Y)-30.57%
    Max Drawdown (3Y)-36.07%
    Sharpe Ratio (1Y)-0.02
    Correlation with SPY (1Y)0.17
    50-Day Average$96.42
    200-Day Average$90.13
    52-Week Range$72.76 to $110.26
    RSI (14 Days)52.7
    Average Volume (20 Days)833.93K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.99x current liabilities, and total debt is 0.48x shareholder equity.

    Current Ratio2.99x
    Quick Ratio2.99x
    Debt / Equity0.48x
    Debt / EBITDA1.85x
    Debt / FCF2.20x
    Interest Coverage6.88x

    Returns and Efficiency

    Return on invested capital is 9.38% over the last 12 months, against a 5-year average of 2.64%.

    Return on Equity (ROE)11.88%
    Return on Assets (ROA)7.23%
    Return on Invested Capital (ROIC)9.38%
    Return on Capital Employed (ROCE)11.59%
    ROE (5Y Average)2.75%
    ROA (5Y Average)1.73%
    ROIC (5Y Average)2.64%
    Asset Turnover0.41x
    Receivables Turnover11.16x

    Taxes

    Income tax took 23.39% of pretax income over the last 12 months.

    Income Tax (TTM)$72.22M
    Effective Tax Rate23.39%

    Scores

    HQY has an Altman Z-Score of 4.94, in the safe zone above 2.99, and a Piotroski F-Score of 9 of 9, in the strong band of 8 or 9.

    Altman Z-Score4.94
    Altman Z ZoneSafe
    Piotroski F-Score9 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $1.36B over the last 12 months is up 7.34% from the 12 months before.

    Revenue$1.36B
    Revenue Growth (YoY)+7.34%
    Gross Profit$970.48M
    Operating Income$351.41M
    Pretax Income$308.71M
    Net Income$236.49M
    EBITDA$519.77M
    EBIT$361.22M
    Reported EPS (TTM)$4.07

    Trailing 12 months through Jul 31, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 60.86% of the $3.27B in total assets.

    Cash and Equivalents$256.00M
    Total Debt$961.05M
    Net Debt$705.04M
    Net Debt Per Share$8.46
    Working Capital$306.43M
    Shareholder Equity$1.99B
    Book Value Per Share$23.87
    Tangible Book Value-$705.83M
    Total Assets$3.27B
    Total Liabilities$1.28B

    Balance sheet as of Jul 31, 2026.

    Full balance sheet

    Cash Flow

    After $53.22M of capital spending, operating cash flow left $436.95M of free cash flow.

    Operating Cash Flow$490.18M
    Capital Expenditures$53.22M
    Free Cash Flow$436.95M
    FCF Per Share$5.28
    Depreciation and Amortization$158.55M
    Share Repurchases$404.50M

    Trailing 12 months through Jul 31, 2026.

    Full cash flow statement

    Margins

    The operating margin is 25.80%, against a 5-year average of 9.54%.

    Gross Margin71.25%
    Operating Margin25.80%
    Pretax Margin22.66%
    Net Margin17.36%
    EBITDA Margin38.16%
    EBIT Margin26.52%
    FCF Margin32.08%
    Gross Margin (5Y Average)61.97%
    Operating Margin (5Y Average)9.54%
    Net Margin (5Y Average)4.23%

    Growth

    Revenue grew 15.08% a year over 3 years, and EPS 43.75% a year.

    Revenue Growth (3Y CAGR)+15.08%
    Revenue Growth (5Y CAGR)+12.36%
    EPS Growth (3Y CAGR)+43.75%
    EPS Growth (5Y CAGR)+19.01%
    FCF Growth (3Y CAGR)+58.76%
    FCF Growth (5Y CAGR)+28.41%
    Operating Income Growth (3Y CAGR)+228.97%
    Book Value Per Share Growth (2Y CAGR)+1.74%

    Revenue and profit by year

    Dividends and Yields

    HQY does not pay a dividend. Its free cash flow yield is 5.15%.

    Earnings Yield4.00%
    FCF Yield5.15%
    Buyback Yield4.76%
    Shareholder Yield4.76%

    Peer Position

    Against 6 similar companies, HQY has the 6th highest P/E and the 3rd highest ROIC.

    P/E Ratio25.0x vs 37.9x median
    P/S Ratio6.2x vs 1.4x median
    ROIC9.38% vs -7.19% median
    Revenue Growth (Trailing 4 Quarters, YoY)+7.34% vs +16.63% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 7.82% and EPS growth at 17.31% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+7.82%
    EPS Growth Forecast (2Y CAGR)+17.31%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HQY

    What is HQY's market cap?

    HealthEquity has a market cap of $8.56B. Its enterprise value, which adds debt and subtracts cash, is $9.26B.

    What is HQY's P/E ratio?

    HealthEquity has a trailing P/E ratio of 25.0x and a forward P/E of 21.3x.

    How many shares of HQY are outstanding?

    HealthEquity has 83.37M shares outstanding. The count is down 3.67% from a year earlier.

    Does HQY pay a dividend?

    No. HealthEquity does not pay a dividend.

    How much debt does HQY have?

    HealthEquity has $961.05M of total debt and $256.00M of cash and equivalents, a net debt position of $705.04M.